Armstrong C, Schubert J, Ueda E, Knez J J, Gelperin D, Hirose S, Silber R, Hollan S, Schmidt R E, Medof M E
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106.
J Biol Chem. 1992 Dec 15;267(35):25347-51.
Deficient expression of glycoinositol phospholipid (GPI) anchored proteins in affected paroxysmal nocturnal hemoglobinuria (PNH) cells has been traced to a defect in GPI anchor assembly. In a previous study (Schubert, J., Schmidt, R. E., and Medof, M. E. (1993) J. Biol. Chem., in press) we characterized the biosynthesis of putative Man-containing GPI anchor precursors in normal peripheral blood lymphocytes and investigated assembly of these intracellular GPI intermediates in CD48- affected and CD48+ unaffected T and natural killer cell lines of PNH patients. We found that affected T cells from five patients exhibited a uniform defect in which dolichol-phosphoryl-Man was synthesized but no GPI mannolipids were expressed. In this study, membranes of patients' affected T cells were labeled with UDP-[3H]GlcNAc to evaluate earlier steps in GPI synthesis, and intact cells were fused to Thy-1- murine lymphoma mutants harboring different defects in early GPI assembly to test for the presence of corresponding or complementary lesions. In all cases, affected cell membranes failed to assemble GlcNAc-inositol phospholipid, the initial precursor of GPI anchor structures, and the intact cells failed to complement class A mutants while complementing other classes. Affected polymorphonuclear leukocytes from three additional patients of different origin were then labeled with [3H]Man and the labeling patterns found to correspond to those obtained with the T lymphocytes. Taken together the data indicate that the genetic lesion in PNH cells resides in a DNA element which: 1) encodes a product required for the synthesis of GlcNAc-inositol phospholipid, 2) corresponds to that altered in class A Thy-1- murine lymphoma mutants, and 3) is commonly affected in different patients.
阵发性睡眠性血红蛋白尿症(PNH)患者受累细胞中糖基磷脂酰肌醇(GPI)锚定蛋白的表达缺陷已被追溯到GPI锚组装缺陷。在先前的一项研究中(舒伯特,J.,施密特,R. E.,和梅多夫,M. E.(1993年)《生物化学杂志》,即将发表),我们对正常外周血淋巴细胞中假定含甘露糖的GPI锚前体的生物合成进行了表征,并研究了这些细胞内GPI中间体在PNH患者的CD48受累和CD48未受累的T细胞系及自然杀伤细胞系中的组装情况。我们发现,来自五名患者的受累T细胞表现出一致的缺陷,即合成了多萜醇磷酸甘露糖,但未表达GPI甘露脂。在本研究中,用UDP-[3H]GlcNAc标记患者受累T细胞的膜,以评估GPI合成的早期步骤,并将完整细胞与在早期GPI组装中存在不同缺陷的Thy-1-小鼠淋巴瘤突变体融合,以检测相应或互补损伤的存在。在所有情况下,受累细胞膜未能组装GPI锚结构的初始前体GlcNAc-肌醇磷脂,完整细胞未能互补A类突变体,而能互补其他类。然后,用[3H]甘露糖标记另外三名不同来源患者的受累多形核白细胞,发现标记模式与T淋巴细胞的一致。综合这些数据表明,PNH细胞中的遗传损伤存在于一个DNA元件中,该元件:1)编码合成GlcNAc-肌醇磷脂所需的产物;2)与A类Thy-1-小鼠淋巴瘤突变体中改变的元件相对应;3)在不同患者中普遍受累。